Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study)

Update your browser to view ScienceDirect.

Request details:

Request ID: 8a0bd623b9decf65-SJC
IP: 116.62.10.13
UTC time: 2024-07-09T22:44:03+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4